Home
Conditions
Eye Neoplasms

Clinical trial condition

Eye Neoplasms

Explore clinical trials studying Eye Neoplasms. Study availability and eligibility vary by location and protocol.

400 public trials 62 recruiting studies

Refine in advanced search Browse all conditions

Eye Neoplasms trial results

Active, not recruiting

A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

NCT04328844

Conditions: Adenoma, Bone Marrow Diseases, Eye Diseases, +34 more
Locations: Humanitas Research Hospital Rozzano, Milan, Italy

Medical Oncology and Immunotherapy Unit, University Hospital of Siena Siena, Italy

Beatson West of Scotland Cancer Centre Glasgow, United Kingdom

View Trial Details

Active, not recruiting

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

NCT03635632

Conditions: Breast Diseases, Breast Neoplasms, Eye Diseases, +36 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, not recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions: 17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations: RTI International Research Triangle Park, North Carolina, United States

View Trial Details

Active, not recruiting

Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma

NCT01783535

Conditions: Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +11 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, not recruiting

Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

NCT01815749

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Blood Protein Disorders, Burkitt Lymphoma, +64 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

NCT05075993

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +46 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

NCT03467516

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Active, not recruiting

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

NCT03941379

Conditions: Choroidal Melanoma, Eye Diseases, Eye Neoplasms, +13 more
Locations: Retina Associates SW, P.C. Tucson, Arizona, United States

UCLA Jules Stein Eye Institute Los Angeles, California, United States

Byers Eye Institute at Stanford University Palo Alto, California, United States

Retina Consultants of Sacramento Sacramento, California, United States

View all 16 locations

View Trial Details

Active, not recruiting

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

NCT04728633

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

NCT04483778

Conditions: Carcinoma, Clear Cell Sarcoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +66 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Eye Neoplasms

Eye Neoplasms trial results

Related conditions